Close Menu

NEW YORK – Genetic Technologies said on Tuesday that it has priced a public offering of 4 million American Depositary Shares (ADSs) at an effective purchase price of $2 per ADS.

Each ADS represents 600 of the Australian molecular diagnostic firm's ordinary shares. Gross proceeds of the offering, which is set to close on May 28, are expected to be roughly $8 million.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.